H3FA (HIST1H3A) Mouse Monoclonal Antibody

CAT#: TA347147

Mouse Monoclonal H3 pan Antibody



Need it in bulk or conjugated?
Get a free quote

CNY 5,255.00


货期*
5周

规格
    • 50 ug

Product images

经常一起买 (2)
Transient overexpression lysate of histone cluster 1, H3a (HIST1H3A)
    • 100 ug

CNY 3,080.00


beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00

Specifications

Product Data
Applications WB
Recommend Dilution ChIP (1-2 µg per IP); Western blotting (1:1,000)
Reactivity Human
Host Mouse
Clonality Monoclonal
Immunogen The immunogen for anti-H3 pan antibody: histone H3, using a KLH-conjugated synthetic peptide containing an unmodified sequence from the C-terminus of the protein.
Concentration lot specific
Purification Protein A purified monoclonal antibody in PBS containing 0.05% azide.
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Gene Name histone cluster 1, H3a
Background Histones are the main constituents of the protein part of chromosomes of eukaryotic cells. They are rich in the amino acids arginine and lysine and have been greatly conserved during evolution. Histones pack the DNA into tight masses of chromatin. Two core histones of each class H2A, H2B, H3 and H4 assemble and are wrapped by 146 base pairs of DNA to form one octameric nucleosome. Histones play a central role in the regulation of transcription, DNA repair, DNA replication and chromosomal stability. These different functions are established via a complex set of post-translational modifications which either directly or indirectly alter chromatin structure and DNA accessibility to facilitate transcriptional activation or repression or other nuclear processes.
Synonyms A; H3; H3FA
Reference Data
Protein Pathways Systemic lupus erythematosus
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...